Cargill sells its Zootech business in France to Bimeda
Minneapolis and Crevin, France – Jan. 6, 2014 – Cargill has sold its Provimi business’s Zootech® brand and French veterinary sales division to Bimeda®, a leading manufacturer and distributor of veterinary pharmaceuticals and animal health products. The terms of the agreement were not disclosed. The transaction closed Dec. 20, 2013, with the transfer effective Jan. 1, 2014.
The sale of this sales division in France is consistent with Cargill Animal Nutrition’s strategy of sharpening its focus on its core animal nutrition solutions and premix activities and concentrating on product lines where it can bring the most value to customers.
The two firms have agreed that Cargill’s Provimi business will continue to manufacture ruminant bolus products for Bimeda, activities that are core to Cargill’s animal nutrition business in France.
“By exiting this non-core business we are able to better position our business in France to capitalize on growth opportunities in the animal nutrition industry,” said Mark Poeschl, vice president and group director for Cargill’s Provimi business. “In addition, Bimeda offers better opportunities for Zootech employees because it is better aligned with Bimeda’s core business activities.”
Niki Larson – [email protected]; 952-742-2122
Cargill provides food, agriculture, financial and industrial products and services to the world. Together with farmers, customers, governments and communities, we help people thrive by applying our insights and nearly 150 years of experience. We have 142,000 employees in 67 countries who are committed to feeding the world in a responsible way, reducing environmental impact and improving the communities where we live and work. For more information, visit Cargill.com and our News Center.